Forbes |
Did You Know St. John’s Wort Might Neutralize Hormonal Contraceptives?
Forbes Doctors later learned that the patients had been taking St. John’s wort and that it was accelerating the breakdown of their transplant rejection drug, cyclosporine. The GlaxoSmithKline researcher, Steven Kliewer, and his colleagues demonstrated in 2000 … |
Organ donation after cardiac death – South Asia Mail
|
Organ donation after cardiac death
South Asia Mail Their daughter had always wanted to donate her organs, but she didn’t meet the brain death criteria required for donation. Her Ottawa family was determined to fulfill her final wish. In 2006, she became the first Canadian in nearly four decades to … |
Initiation of dialysis for acute kidney injury potentially dangerous for frail … – Science Codex
|
Initiation of dialysis for acute kidney injury potentially dangerous for frail …
Science Codex PHILADELPHIA – The decision to initiate dialysis for acute kidney injury (AKI) varies depending on different patient factors and there is a lack of robust evidence as to which patients are likely to benefit most and why. A new study from researchers at … In AKI, Dialysis Works Better With Higher CreatinineMedPage Today AKI Predictors in Lymphoma Patients IdentifiedRenal and Urology News |
Initiation of dialysis for acute kidney injury potentially dangerous for frail … – EurekAlert (press release)
|
Initiation of dialysis for acute kidney injury potentially dangerous for frail …
EurekAlert (press release) PHILADELPHIA – The decision to initiate dialysis for acute kidney injury (AKI) varies depending on different patient factors and there is a lack of robust evidence as to which patients are likely to benefit most and why. A new study from researchers at … |
North Shore-LIJ Cancer Institute Doctors' Editorial Published in The New … – PR Web (press release)
|
North Shore-LIJ Cancer Institute Doctors’ Editorial Published in The New …
PR Web (press release) Researchers compared the benefits of obinutuzumab with that of another antibody rituximab, which also attacks CD20. Both drugs were combined with the chemotherapy drug chlorambucil. They found that subjects receiving obinutuzumab-chlorambucil had … |
LIVE MEDTALK: Treating Congestive Heart Failure and the Role of Payment … – Brookings Institution
|
LIVE MEDTALK: Treating Congestive Heart Failure and the Role of Payment …
Brookings Institution In a new and exciting “MEDTALK” format that converges medicine, education and delivery reform, the Engelberg Center for Health Care Reform presents the Merkin Series on Innovations in Care Delivery. These unique learning opportunities will allow … |
The Diminishing Returns of Modern Medicine – New York Times (blog)
New York Times (blog)The Diminishing Returns of Modern MedicineNew York Times (blog)This golden period has witnessed a hailstorm of life-prolonging advances, including implantable pacemakers, coronary bypass surgery and heart transplantation. Cardiovas…
Researchers identify 'bendopnea' as new symptom for heart failure – ModernHealthcare.com (blog)
|
Researchers identify ‘bendopnea’ as new symptom for heart failure
ModernHealthcare.com (blog) If a patient with heart failure experiences shortness of breath as he or she leans forward to tie a shoelace or put on a sock, it might be an overlooked sign that their disease is advancing, a new study finds. Researchers coined the term “bendopnea” to … |
Apollo's Fire benefit, Happy Tails Cat Sanctuary, Yuri's Night party, opera … – The Plain Dealer
|
Apollo’s Fire benefit, Happy Tails Cat Sanctuary, Yuri’s Night party, opera …
The Plain Dealer Freewill donations. Tremont History Project presents a locally filmed episode of “Route 66.” “First Class Mouliak” (1961) features Robert Redford in an early role. Supports Tremont History Project. Popcorn, soda, coffee and tea will be served. Parking … |
FDA Wants More Info on Avedro's Corneal Cross-Linking NDA – Medscape
|
FDA Wants More Info on Avedro’s Corneal Cross-Linking NDA
Medscape “Patients with these sight threatening conditions may require corneal transplant surgery. If approved, the riboflavin ophthalmic solution/KXL System would be the first FDA-approved therapeutic treatment for these orphan indications,” the company said. |